Tulane University School of Medicine Dermatology Residency
For a broader understanding of peptide safety across different compounds, our guide on safe peptides for women and peptides for women over 40 address gender-specific safety considerations
Some kept selling GLP-1 knockoffs anyway, leading regulators to crack down on false advertising and bootleg sales
Reported Adverse Effects In the available case series and observational literature, the most commonly reported adverse effects include: Injection-site redness or mild induration in approximately 8 to 12% of users Transient nausea, most often associated with oral formulations or higher injectable doses Lightheadedness in a small number of patients shortly after injection (under 2% of reported cases) Vivid dreams or mild sleep changes, reported anecdotally by a subset of users with no clear mechanistic explanation No published human case reports as of July 2025 document serious organ toxicity, malignancy, or endocrine disruption attributable to BPC-157
This biphasic response curve, where both microgram and nanogram doses work equally well, is unusual and mechanistically unclear
